Published on 4 May 2023 on Zacks via Yahoo Finance
Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates
Veracyte (VCYT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 21.43%. A quarter ago, it was expected that this molecular diagnostic company would post a loss of $0.15 per share when it actually produced a loss of $0.05, delivering a surprise of 66.67%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.